Alveolar rhabdomyosarcoma (ARMS) is the second most common subtype of
rhabdomyosarcoma, accounting for approximately 20% of cases. ARMS is
associated with the chromosomal translocations t(2;13)(q35;q14) and
t(1;13)(p36;q14) resulting in the fusion proteins PAX3-FOXO1 and PAX7-
FOXO1, respectively. The molecular mechanisms by which PAX3-FOXO1
contribute to ARMS formation remains to be fully determined. However the
data reported in this thesis demonstrate the functional interaction of novel
ARMS associated genes with PAX3-FOXO1 and their contribution to the
development of ARMS. The research performed in our laboratory is focused
on defining the molecular biology behind PAX3-FOXO1-induced
tumorigenesis. Published and unpublished data from this laboratory shows
that expression of PAX3-FOXO1 alone is not sufficient for the transformation
of primary mouse myoblasts (Lagutina, Pritchard and Grosveld, unpublished
data). Abrogation of both the p53 and Rb pathways is required in order to
allow PAX3-FOXO1 driven transformation (Lagutina, Pritchard and Grosveld,
unpublished data). My research is focused on the identification of these
PAX3-FOXO1-complementing secondary events using a cDNA library screen.
To this end, chapter 3 describes the identification of a novel gene named
IRIZIO and its cooperation with PAX3-FOXO1 in transforming Arf-/- myoblasts
in vivo. Similarly, chapter 4 illustrates the effect of lysil hydroxylase 1 (PLOD1)
and its tumorigenic capacity when over expressed together with PAX3-FOXO1
in myogenic cells. Together, these results contribute to a better understanding
of the mechanisms by which PAX3-FOXO1 and its cooperating proteins
mediate myogenic cell transformation. Hopefully our findings will eventually
contribute to improve the treatment of ARMS
http://repub.eur.nl/res/pub/30798/120104_Picchione%2C%20Fabrizio.pdf
http://repub.eur.nl/res/pub/30798/120104_Picchione%2C%20Fabrizio.pdf
No comments:
Post a Comment